NCT00964288View on ClinicalTrials.gov

Effect of GSK1014802 on Electrical Hyperalgesia and Threshold Tracking in Healthy Subjects

PHASE1TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Pain, NeuropathicNeuropathic Pain
Interventions
DRUG

GSK1014802 low dose

oral tablet

DRUG

Lidocaine

positive control

DRUG

GSK1014802 high dose

oral tablet

DRUG

Placebo

To match GSK drug and positive control

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY